Why Are People Injecting Themselves with Peptides? The New Yorker In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for BPC 157: Miracle Healing Peptide or Hidden Danger? FDA takes first step in possible reversal of ban on some peptides The Washington Post